Opioids

Racial/Ethnic, Income Variation Identified in the Opioid Epidemic

Racial/Ethnic, Income Variation Identified in the Opioid Epidemic

Researchers found that the prevalence of opioid prescriptions varied nearly 300% across the race/ethnicity-income gradient.

Opioid-Related Pediatric Deaths Increased 3-Fold Between 1999 and 2016

Opioid-Related Pediatric Deaths Increased 3-Fold Between 1999 and 2016

By

The rate of pediatric mortality associated with prescription and illicit opioids rose 3-fold between 1999 and 2016.

An Evidence-Based Road Map to Navigating the Opioid Epidemic

An Evidence-Based Road Map to Navigating the Opioid Epidemic

By

This rise in prescribing of prescription opioids in the last 2 decades of the 20th century occurred at a time during which medical professionals were urged to resort to prescription opioids to manage untreated and chronic noncancer pain.

AHA Online Opioid Education Course Available

AHA Online Opioid Education Course Available

By

The American Heart Association launched in December 2018 a 30 minute-long online course titled "Opioid Education for Healthcare Providers."

As Shutdown Drags On, Opioid Crisis Looms Large

As Shutdown Drags On, Opioid Crisis Looms Large

By

As the government shutdown drags in to its second month, physicians who treat opioid use disorders are being backed against a wall.

Opioids Now More Deadly for Americans Than Traffic Accidents

Opioids Now More Deadly for Americans Than Traffic Accidents

For the first time in history, Americans' risk for dying from an opioid overdose is higher than their risk for dying in a car accident.

reSET-O Digital Therapeutic for Opioid Use Disorder Now Available

reSET-O Digital Therapeutic for Opioid Use Disorder Now Available

By

Sandoz and Pear Therapeutics announced the launch of reSET-O, a new digital therapeutic for patients aged ≥18 years with opioid use disorder (OUD) currently under clinician care.

A Case for Ministerial Recall of High-Strength Opioids in Canada

A Case for Ministerial Recall of High-Strength Opioids in Canada

By

The Protecting Canadians from Unsafe Drugs Act passed into law in 2014 empowered the minister of health to recall a drug if they "believe that a therapeutic product presents a serious or imminent risk of injury to health."

More Than Two-Thirds of Overdose Deaths in 2017 Involved Opioids

More Than Two-Thirds of Overdose Deaths in 2017 Involved Opioids

More than two-thirds of drug overdose deaths in 2017 involved an opioid, with increases in overdose deaths from all opioids and synthetic opioids seen from 2016 to 2017.

Prescription Digital Therapeutic Approved for Opioid Use Disorder

Prescription Digital Therapeutic Approved for Opioid Use Disorder

By

reSET-O is intended for use as an adjunct to outpatient treatment that includes transmucosal buprenorphine (medication-assisted-treatment [MAT]) and contingency management for patients aged ≥18 years who are currently under clinician supervision.

Opioids: Clinician Concern and Prescribing Practices

Opioids: Clinician Concern and Prescribing Practices

By

Clinicians who are highly concerned about opioid misuse, addiction, and psychological dependence may be more confident but also more reluctant to prescribe opioids.

Addiction Medicine Consultation Improves Antibiotic Compliance in Patients with Opioid Use Disorders

Addiction Medicine Consultation Improves Antibiotic Compliance in Patients with Opioid Use Disorders

Patients with opioid use disorders who required hospitalization with lengthy antibiotic therapy had better outcomes with addiction medicine consultation.

Additional Measures Needed for a Comprehensive Public Health Approach to the Opioid Crisis

Additional Measures Needed for a Comprehensive Public Health Approach to the Opioid Crisis

In an effort to address the ongoing opioid crisis adequately, a set of measures complementing the current efforts at state and federal levels would need to be implemented for a more "coordinated and comprehensive approach" to the issue.

Updated Evidence-Based Recommendations for Buprenorphine Treatment

Updated Evidence-Based Recommendations for Buprenorphine Treatment

By

Seven key practice areas for the use of buprenorphine for the treatment of opioid use disorders were updated with new evidence-based recommendations.

FDA Cracks Down on Companies Selling Dietary Supplements Containing Tianeptine

FDA Cracks Down on Companies Selling Dietary Supplements Containing Tianeptine

By

While approved in Europe, Asia and Latin America, tianeptine is an unscheduled pharmaceutical agent in the US that has been linked to serious adverse events, including death, when used for recreational purposes.

Examining the Effect of State Laws Restricting Access to Methadone on Overdose Death Rates

Examining the Effect of State Laws Restricting Access to Methadone on Overdose Death Rates

By

The law restricting access to medication-assisted treatment with methadone to opioid treatment programs may have contributed to reducing opioid-related overdose death rates in the United States.

FDA Panel Votes in Favor of Abuse-Deterrent Oxycodone Reformulation

FDA Panel Votes in Favor of Abuse-Deterrent Oxycodone Reformulation

By

The vote was taken in a joint meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee.

The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists

The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists

The guideline formulated by the Centers for Disease Control and Prevention in an effort to curb opioid overdose-related deaths included a recommendation for steep reductions in opioid doses for patients taking high doses of the drug for chronic pain.

Bill to Fight US Opioid Crisis Signed Into Law

Bill to Fight US Opioid Crisis Signed Into Law

A bipartisan bill meant to combat the United States' opioid abuse epidemic was signed into law on October 24, 2018.

CDC Guideline for Opioid Prescribing May Have Effectively Reduced Opioid Prescribing Practices

CDC Guideline for Opioid Prescribing May Have Effectively Reduced Opioid Prescribing Practices

By

The Centers for Disease Control and Prevention's "Guideline for Prescribing Opioids for Chronic Pain" may have contributed to a further reduction in several opioid prescribing practices.

Rates of Concurrent Opioid, Sedative-Hypnotic Prescription Fills in Veterans

Rates of Concurrent Opioid, Sedative-Hypnotic Prescription Fills in Veterans

By

A high percentage of post-9/11 veterans receiving Veterans Health Administration care were found to take concurrent prescription opioids and sedative hypnotics.

Failure of the Criminal Justice System to Accommodate Methadone Limits Addiction Recovery Among Incarcerated Individuals

Failure of the Criminal Justice System to Accommodate Methadone Limits Addiction Recovery Among Incarcerated Individuals

By

Despite the positive effects, just 55% of federal prison medical directors report offering methadone, and even fewer offer buprenorphine.

Role of the Perioperative Surgical Home in the Context of the Opioid Epidemic

Role of the Perioperative Surgical Home in the Context of the Opioid Epidemic

By

The integration of a Transitional Pain Service into a perioperative surgical home model could optimize perioperative pain control and opioid use, while reducing postdischarge hospital readmissions as well as the costs and disability linked to chronic postsurgical pain.

Does Robust Documentation Decrease Opioid Prescribing Rates?

Does Robust Documentation Decrease Opioid Prescribing Rates?

By

Accurate, transparent documentation is key in ensuring safe and appropriate opioid prescribing.

FDA Outlines Plan for New Analgesic Guidance to Combat Opioid Crisis

FDA Outlines Plan for New Analgesic Guidance to Combat Opioid Crisis

By

The new plan will break out the current guidance into 4 separate guidances.

DEA Proposal Will Significantly Cut Opioid Manufacturing in 2019

DEA Proposal Will Significantly Cut Opioid Manufacturing in 2019

By

Last year, the DEA proposed a 20% reduction in the manufacturing of controlled substances for 2018 compared to 2017.

Researchers Question DEA Hydrocodone Schedule Change in Light of Postoperative Prescribing Practice Data

Researchers Question DEA Hydrocodone Schedule Change in Light of Postoperative Prescribing Practice Data

By

The US Drug Enforcement Administration rescheduled hydrocodone-containing analgesics from schedule III to schedule II in October 2014.

Examining the Effect of Chronic Opioid Use on 2016 Presidential Voting Patterns

Examining the Effect of Chronic Opioid Use on 2016 Presidential Voting Patterns

By

Chronic use of prescription opioids was correlated with support for the Republican candidate in the 2016 presidential election.

Lowering Default Pill Counts in EMRs May Effectively Reduce Postoperative Opioid Prescription Numbers

Lowering Default Pill Counts in EMRs May Effectively Reduce Postoperative Opioid Prescription Numbers

By

Lowering the default number of opioid pills prescribed in an electronic medical record system can significantly decrease the amount of opioid medication prescribed after procedures.

The Opioid Crisis: District by District

The Opioid Crisis: District by District

By

Southern states have the 10 highest opioid prescribing rates in the country, while California, New York, and Virginia are among the bottom 10.

Free E-Newsletter